Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v7-EN
Language English English
Date Updated 2018-01-04 2018-01-03
Drug Identification Number 00613223 00613223
Brand name TEVA-SPIRONOLACTONE TEVA-SPIRONOLACTONE
Common or Proper name SPIRONOLACTONE SPIRONOLACTONE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SPIRONOLACTONE SPIRONOLACTONE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C03DA C03DA
ATC description POTASSIUM-SPARING AGENTS POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-03 2018-01-03
Estimated end date 2018-01-19 2018-01-19
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments